Several conditions-such as GLUT1 deficiency, cerebrotendinous xanthomatosis, and folate receptor α deficiency-are treatable through dietary or pharmacological interventions. The gene discussed is SLC2A1; the disease is hyperinsulinemic hypoglycemia, familial, 4.